Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
BMC Molecular and Cell Biology|October 31, 2020
IL6/sIL6R regulates TNFα-inflammatory response in synovial fibroblasts through modulation of transcriptional and post-transcriptional mechanismsAlvaro Valin, Manuel J Del Rey, Cristina Municio, et al.
Pigment Cell & Melanoma Research|November 29, 2016
DEK oncogene is overexpressed during melanoma progressionErica Riveiro-Falkenbach, Yolanda Ruano, Rosa M García-Martín, et al.
Journal of Neuropathology and Experimental Neurology|February 20, 2009
Novel genomic alterations and mechanisms associated with tumor progression in oligodendroglioma and mixed oligoastrocytomaDavid Blesa, Manuela Mollejo, Yolanda Ruano, et al.
The Journal of Investigative Dermatology|June 18, 2015
Intra- and Inter-Tumoral Homogeneity of BRAF(V600E) Mutations in Melanoma TumorsErica Riveiro-Falkenbach, Cándida A Villanueva, María C Garrido, et al.
Heliyon|August 23, 2023
pTERT C250T mutation: A potential biomarker of poor prognosis in metastatic melanomaLeyla Blanco-García, Yolanda Ruano, Raquel Blanco Martínez-Illescas, et al.
JTO Clinical and Research Reports|February 25, 2025
Clinical Utility of Combined Tissue and Plasma Next-Generation Sequencing in Patients With Advanced, Treatment-Naïve NSCLCHelena Bote-de Cabo, Marco Siringo, Esther Conde, et al.
International Journal of Molecular Sciences|June 26, 2026
Implementation of HER2DX Scores into Treatment Decisions in Early-Stage HER2-Positive Breast CancerLola R Nogueira, Ana Maderuelo, Manuel Alva Bianchi, et al.
Neuro-Oncology|August 6, 2010
Differential expression profiling analyses identifies downregulation of 1p, 6q, and 14q genes and overexpression of 6p histone cluster 1 genes as markers of recurrence in meningiomasElisa Pérez-Magán, Angel Rodríguez de Lope, Teresa Ribalta, et al.
Breast Cancer Research and Treatment|July 14, 2026
Real-world clinical outcomes of intermediate-risk PAM50 (i-ROR) in HR+/HER2- early breast cancer and eligibility for adjuvant CDK4/6 inhibitorsSantiago Terán, María Illia, María Carla Quevedo, et al.
Cancers|November 5, 2020
Immune Profiling of Gliomas Reveals a Connection with IDH1/2 Mutations, Tau Function and the Vascular PhenotypeTeresa Cejalvo, Ricardo Gargini, Berta Segura-Collar, et al.
Pageof 4